AI assistant
RECCE PHARMACEUTICALS LTD — Capital/Financing Update 2024
Aug 5, 2024
65669_rns_2024-08-05_c20f2521-086c-4b33-81fa-6442127a09c3.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer

Announcement Summary
Entity name
RECCE PHARMACEUTICALS LTD
Announcement Type
New announcement
Date of this announcement
Tuesday August 06, 2024
The +securities to be quoted are:
Total number of +securities to be quoted +Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B
| ASX +securitycode | Security description | Number of +securities tobe quoted | Issue date |
|---|---|---|---|
| RCE | ORDINARY FULLY PAID | 9,844,296 | 06/08/2024 |
Refer to next page for full details of the announcement

Part 1 - Entity and announcement details
1.1 Name of entity
RECCE PHARMACEUTICALS LTD
We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.
1.2 Registered number type
ACN
Registration number
124849065
1.3 ASX issuer code
RCE
1.4 The announcement is 1.5 Date of this announcement New announcement
6/8/2024

Part 2 - Type of Issue
2.1 The +securities to be quoted are:
+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B
| Previous Appendix 3B details: | |||||
|---|---|---|---|---|---|
| Announcement Date andTime | Announcement Title | Selected Appendix 3B to submit quotationrequest | |||
| 02-Jul-2024 10:23 | New - Proposed issue of securities -RCE | An offer of +securities under a +securitiespurchase plan |
2.3a.2 Are there any further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B?
No

Part 3A - number and type of +securities to be quoted where issue has previously been notified to ASX in an Appendix 3B
Corporate Action Component Detail
ASX +security code and description
RCE : ORDINARY FULLY PAID
Issue date
6/8/2024
Distribution Schedule
Provide a distribution schedule for the new +securities according to the categories set out in the left hand column including the number of recipients and the total percentage of the new +securities held by the recipients in each category.
| Number of +securities held | Number of holders | Total percentage of +securities heldFor example, to enter a value of 50%please input as 50.00 |
|---|---|---|
| 1 - 1,000 | % | |
| 1,001 - 5,000 | % | |
| 5,001 - 10,000 | % | |
| 10,001 - 100,000 | % | |
| 100,001 and over | % |

Issue details
Number of +securities to be quoted 9,844,296 Issue currency AUD - Australian Dollar Issue price or consideration per +security AUD 0.45000000
Any other information the entity wishes to provide about the +securities to be quoted
The SPP closed oversubscribed, the initial target raise being $2 million. In accordance with the terms of the SPP, the Board exercised its discretion and determined to accept all valid applications in full to raise $4.4 million under the SPP.

Part 4 - Issued capital following quotation
| Following the quotation of the +securities the subject of this application, the issued capital of the entity willcomprise: | ||||
|---|---|---|---|---|
| The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital ifother Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing. | ||||
| 4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the+securities subject of this application) | ||||
| ASX +security code and description | Total number of+securities on issue | |||
| RCE : ORDINARY FULLY PAID | 231,609,328 | |||
| 4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX) | ||||
| ASX +security code and description | Total number of+securities on issue | |||
| RCEAH : PERFORMANCE SHARES | 8,754,423 | |||
| RCEAW : OPTION EXPIRING 11-FEB-2027 EX $1.56 | 435,000 | |||
| RCEAU : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES | 1,125,000 | |||
| RCEAN : OPTION EXPIRING 22-FEB-2026 EX $1.56 | 8,415,000 |